Companies / West Pharmaceutical Services Inc / Activity
Activity — West Pharmaceutical Services Inc
67 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Favorite Annette F Executive | Sell | Common Stock | $859.8K | -3K -14.34% | 16,828 0.02% of shares | medium |
| Feb 17, 2026 | Green Eric Mark CEO | Other | Common Stock | $317.5K | -1K -0.75% | 172,895 0.25% of shares | low |
| Feb 11, 2026 | McMahon Robert W. Executive | Other | Common Stock | $307.7K | -1K -29.55% | 2,980 <0.01% of shares | low |
| Apr 27, 2026 | Winters Chad Executive | Sell | Common Stock | $269.4K | -896 -37.04% | 1,523 <0.01% of shares | medium |
| Apr 27, 2026 | Favorite Annette F Executive | Exercise | Common Stock | $235.1K | +3K +16.74% | 19,645 0.03% of shares | low |
| Apr 27, 2026 | Winters Chad Executive | Exercise | Common Stock | $155.2K | +896 +58.84% | 2,419 <0.01% of shares | low |
| Feb 18, 2026 | Green Eric Mark CEO | Other | Common Stock | $142.4K | -574 -0.33% | 175,161 0.25% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Other | Common Stock | $42.1K | -135 -18.05% | 613 <0.01% of shares | low |
| Feb 17, 2026 | Favorite Annette F Executive | Other | Common Stock | $36.6K | -150 -0.86% | 17,275 0.02% of shares | low |
| Feb 20, 2026 | Poussot Rodolphe Jean Executive | Other | Common Stock | $31.2K | -130 -18.75% | 561 <0.01% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Other | Common Stock | $26.3K | -84 -23.53% | 274 <0.01% of shares | low |
| Feb 17, 2026 | Winters Chad Executive | Other | Common Stock | $12.3K | -51 -3.34% | 1,462 <0.01% of shares | low |
| Feb 17, 2026 | Witherspoon Charles Executive | Other | Common Stock | $10.1K | -42 -2.94% | 1,370 <0.01% of shares | low |
| Feb 18, 2026 | Favorite Annette F Executive | Other | Common Stock | $8.9K | -36 -0.21% | 17,374 0.02% of shares | low |
| Feb 20, 2026 | Winters Chad Executive | Other | Common Stock | $7.3K | -30 -1.94% | 1,523 <0.01% of shares | low |
| Feb 18, 2026 | Poussot Rodolphe Jean Executive | Other | Common Stock | $6.9K | -28 -8.30% | 307 <0.01% of shares | low |
| Feb 20, 2026 | Witherspoon Charles Executive | Other | Common Stock | $5.3K | -22 -1.54% | 1,408 <0.01% of shares | low |
| May 4, 2026 | Pucci Paolo Director | Grant | Common Stock | $0 | +791 +7.15% | 11,854 0.02% of shares | low |
| May 4, 2026 | Michels Douglas A Director | Grant | Common Stock | $0 | +791 +1.73% | 46,496 0.07% of shares | low |
| May 4, 2026 | Lockhart Stephen H Director | Grant | Common Stock | $0 | +791 +28.95% | 3,523 <0.01% of shares | low |
| May 4, 2026 | Lai Goldman Myla Director | Grant | Common Stock | $0 | +791 +4.03% | 20,435 0.03% of shares | low |
| May 4, 2026 | Keller Deborah L Director | Grant | Common Stock | $0 | +791 +7.34% | 11,560 0.02% of shares | low |
| May 4, 2026 | Joseph Molly Director | Grant | Common Stock | $0 | +791 +21.93% | 4,398 <0.01% of shares | low |
| May 4, 2026 | Haugen Janet Brutschea Director | Grant | Common Stock | $0 | +791 +50.01% | 2,373 <0.01% of shares | low |
| May 4, 2026 | Friel Robert F Director | Grant | Common Stock | $0 | +791 +16.75% | 5,513 <0.01% of shares | low |
| May 4, 2026 | Feehery William F Director | Grant | Common Stock | $0 | +791 +2.49% | 32,519 0.05% of shares | low |
| May 4, 2026 | Buthman Mark a Director | Grant | Common Stock | $0 | +791 +1.82% | 44,309 0.06% of shares | low |
| Feb 17, 2026 | Winters Chad Executive | Grant | Common Stock | $0 | +150 +10.98% | 1,513 <0.01% of shares | low |
| Feb 17, 2026 | Witherspoon Charles Executive | Grant | Common Stock | $0 | +116 +8.95% | 1,411 <0.01% of shares | low |
| Feb 17, 2026 | Favorite Annette F Executive | Grant | Common Stock | $0 | +442 +2.60% | 17,425 0.02% of shares | low |
| Feb 17, 2026 | Green Eric Mark CEO | Grant | Common Stock | $0 | +4K +2.60% | 174,200 0.25% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Exercise | Rst. Stock Unit | — | -474 -25.04% | 1,417 <0.01% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Exercise | Rst. Stock Unit | — | -296 -25.04% | 886 <0.01% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Exercise | Common Stock | — | +474 +172.76% | 748 <0.01% of shares | low |
| May 12, 2026 | Campbell Shane Alden Executive | Exercise | Common Stock | — | +296 +473.86% | 358 <0.01% of shares | low |
| Apr 27, 2026 | Favorite Annette F Executive | Exercise | Stock Options (Right to Buy) | — | -3K -33.33% | 5,635 <0.01% of shares | low |
| Apr 27, 2026 | Winters Chad Executive | Exercise | Stock Options (Right to Buy) | — | -896 -100.00% | 0 0.00% of shares | low |
| Mar 31, 2026 | Haugen Janet Brutschea Director | Grant | Phantom Stock Unit | — | +52 +24.94% | 260 <0.01% of shares | low |
| Mar 1, 2026 | Winters Chad Executive | Grant | Stock Option (Right to Buy) | — | +808 | 808 <0.01% of shares | low |
| Mar 1, 2026 | Winters Chad Executive | Grant | Rst. Stock Unit | — | +340 | 340 <0.01% of shares | low |
| Feb 20, 2026 | Winters Chad Executive | Exercise | Rst. Stock Unit | — | -89 -25.00% | 268 <0.01% of shares | low |
| Feb 20, 2026 | Winters Chad Executive | Exercise | Common Stock | — | +89 +6.10% | 1,553 <0.01% of shares | low |
| Feb 20, 2026 | Witherspoon Charles Executive | Exercise | Rst. Stock Unit | — | -60 -25.32% | 178 <0.01% of shares | low |
| Feb 20, 2026 | Witherspoon Charles Executive | Exercise | Common Stock | — | +60 +4.40% | 1,430 <0.01% of shares | low |
| Mar 1, 2026 | Favorite Annette F Executive | Grant | Stock Option (Right to Buy) | — | +2K | 1,712 <0.01% of shares | low |
| Mar 1, 2026 | Favorite Annette F Executive | Grant | Rst. Stock Unit | — | +720 | 720 <0.01% of shares | low |
| Feb 18, 2026 | Favorite Annette F Executive | Exercise | Rst. Stock Unit | — | -135 -24.91% | 408 <0.01% of shares | low |
| Feb 18, 2026 | Favorite Annette F Executive | Exercise | Common Stock | — | +135 +0.78% | 17,410 0.02% of shares | low |
| Mar 1, 2026 | McMahon Robert W. Executive | Grant | Stock Option (Right to Buy) | — | +7K | 7,337 0.01% of shares | low |
| Mar 1, 2026 | McMahon Robert W. Executive | Grant | Rst. Stock Unit | — | +3K | 3,082 <0.01% of shares | low |